Status | Study |
Completed |
Study Name: Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing Condition: Acute Myeloid Leukemia Date: 2016-07-08 Interventions: Other: DNA sequencing |
Withdrawn |
Study Name: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia Condition: Leukemia, Myeloid, Acute Leukemia, Monocytic, Acute Leukem Date: 2015-07-06 Interventions: Drug: Volasertib Addition of s |
Recruiting |
Study Name: Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR Condition: Leukemia, Erythroblastic, Acute Myelodysplastic Syndromes Date: 2015-02-19 Interventions: Drug: 5-Azacytidine |
Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia Date: 2014-01-28 Interventions: Drug: MEK inhibitor MEK162 Giv |
Terminated |
Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Megakaryob Date: 2014-01-15 Interventions: Drug: Lenalidomide Given PO |
Completed |
Study Name: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2013-06-03 Interventions: Drug: Cytarabine Given IV |
Recruiting |
Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2013-02-26 Interventions: Drug: mitoxantrone hydrochloride |
Completed |
Study Name: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2011-08-31 Interventions: Drug: cyclophosphamide Given I |
Active, not recruiting |
Study Name: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Megakaryob Date: 2011-08-19 Interventions: Drug: Bortezomib Given SC |
Completed |
Study Name: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2011-05-24 Interventions: Drug: Tipifarnib Given PO |